| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
SDGC.F Stock Overview
Sundrug Co.,Ltd. operates and manages drug stores and dispensing pharmacies in Japan.
SundrugLtd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥22.68 |
| 52 Week High | JP¥34.22 |
| 52 Week Low | JP¥22.68 |
| Beta | 0.53 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | -41.14% |
| 3 Year Change | -13.86% |
| 5 Year Change | -31.52% |
| Change since IPO | -0.53% |
Recent News & Updates
Shareholder Returns
| SDGC.F | US Consumer Retailing | US Market | |
|---|---|---|---|
| 7D | n/a | -0.8% | -2.5% |
| 1Y | -41.1% | 11.1% | -10.4% |
Return vs Industry: SDGC.F underperformed the US Consumer Retailing industry which returned 13.5% over the past year.
Return vs Market: SDGC.F underperformed the US Market which returned -10.8% over the past year.
Price Volatility
| SDGC.F volatility | |
|---|---|
| SDGC.F Average Weekly Movement | n/a |
| Consumer Retailing Industry Average Movement | 6.7% |
| Market Average Movement | 7.8% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: Insufficient data to determine SDGC.F's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine SDGC.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1957 | 5,634 | Koji Sadakata | https://www.sundrug.co.jp |
Sundrug Co.,Ltd. operates and manages drug stores and dispensing pharmacies in Japan. It also operates discount stores that offers food, cosmetics, home appliances, clothing, car supplies, sports and goods, alcoholic beverages, and pharmaceutical products, as well as fresh food, kerosene, etc. The company was founded in 1957 and is headquartered in Fuchu, Japan.
SundrugLtd Fundamentals Summary
| SDGC.F fundamental statistics | |
|---|---|
| Market Cap | JP¥341.18b |
| Earnings (TTM) | JP¥23.61b |
| Revenue (TTM) | JP¥645.19b |
14.5x
P/E Ratio0.5x
P/S RatioIs SDGC.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SDGC.F income statement (TTM) | |
|---|---|
| Revenue | JP¥645.19b |
| Cost of Revenue | JP¥488.32b |
| Gross Profit | JP¥156.87b |
| Other Expenses | JP¥133.26b |
| Earnings | JP¥23.61b |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
May 13, 2022
| Earnings per share (EPS) | 201.91 |
| Gross Margin | 24.31% |
| Net Profit Margin | 3.66% |
| Debt/Equity Ratio | 0.0% |
How did SDGC.F perform over the long term?
See historical performance and comparisonDividends
2.4%
Current Dividend Yield35%
Payout RatioValuation
Is SundrugLtd undervalued compared to its fair value and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry
40.9%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: SDGC.F ($22.68) is trading below our estimate of fair value ($38.35)
Significantly Below Fair Value: SDGC.F is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: SDGC.F is good value based on its PE Ratio (14.5x) compared to the US Consumer Retailing industry average (18.9x).
PE vs Market: SDGC.F is good value based on its PE Ratio (14.5x) compared to the US market (15.3x).
Price to Earnings Growth Ratio
PEG Ratio: SDGC.F is poor value based on its PEG Ratio (3.1x)
Price to Book Ratio
PB vs Industry: SDGC.F is good value based on its PB Ratio (1.6x) compared to the US Consumer Retailing industry average (2x).
Future Growth
How is SundrugLtd forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
Future Growth Score
1/6Future Growth Score 1/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
4.6%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SDGC.F's forecast earnings growth (4.6% per year) is above the savings rate (1.9%).
Earnings vs Market: SDGC.F's earnings (4.6% per year) are forecast to grow slower than the US market (12.3% per year).
High Growth Earnings: SDGC.F's earnings are forecast to grow, but not significantly.
Revenue vs Market: SDGC.F's revenue (4.4% per year) is forecast to grow slower than the US market (7.8% per year).
High Growth Revenue: SDGC.F's revenue (4.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SDGC.F's Return on Equity is forecast to be low in 3 years time (10.8%).
Past Performance
How has SundrugLtd performed over the past 5 years?
Past Performance Score
2/6Past Performance Score 2/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
0.7%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SDGC.F has high quality earnings.
Growing Profit Margin: SDGC.F's current net profit margins (3.7%) are lower than last year (4%).
Past Earnings Growth Analysis
Earnings Trend: SDGC.F's earnings have grown by 0.7% per year over the past 5 years.
Accelerating Growth: SDGC.F's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: SDGC.F had negative earnings growth (-7.1%) over the past year, making it difficult to compare to the Consumer Retailing industry average (1.5%).
Return on Equity
High ROE: SDGC.F's Return on Equity (10.9%) is considered low.
Financial Health
How is SundrugLtd's financial position?
Financial Health Score
6/6Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage
Financial Position Analysis
Short Term Liabilities: SDGC.F's short term assets (¥201.2B) exceed its short term liabilities (¥97.7B).
Long Term Liabilities: SDGC.F's short term assets (¥201.2B) exceed its long term liabilities (¥8.4B).
Debt to Equity History and Analysis
Debt Level: SDGC.F is debt free.
Reducing Debt: SDGC.F has not had any debt for past 5 years.
Debt Coverage: SDGC.F has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: SDGC.F has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Dividend
What is SundrugLtd current dividend yield, its reliability and sustainability?
Dividend Score
4/6Dividend Score 4/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage
2.40%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: SDGC.F's dividend (2.4%) is higher than the bottom 25% of dividend payers in the US market (1.56%).
High Dividend: SDGC.F's dividend (2.4%) is low compared to the top 25% of dividend payers in the US market (4.08%).
Stability and Growth of Payments
Stable Dividend: SDGC.F's dividends per share have been stable in the past 10 years.
Growing Dividend: SDGC.F's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (34.7%), SDGC.F's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (68.3%), SDGC.F's dividend payments are covered by cash flows.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
11.3yrs
Average management tenure
CEO
Koji Sadakata
3.08yrs
Tenure
Koji Sadakata serves as CEO, President & Representative Director at Sundrug Co.,Ltd.
Leadership Team
Experienced Management: SDGC.F's management team is seasoned and experienced (11.3 years average tenure).
Board Members
Experienced Board: SDGC.F's board of directors are considered experienced (9.9 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Sundrug Co.,Ltd.'s employee growth, exchange listings and data sources
Key Information
- Name: Sundrug Co.,Ltd.
- Ticker: SDGC.F
- Exchange: OTCPK
- Founded: 1957
- Industry: Drug Retail
- Sector: Consumer Retailing
- Implied Market Cap: JP¥341.183b
- Listing Market Cap: JP¥2.640b
- Shares outstanding: 116.92m
- Website: https://www.sundrug.co.jp
Number of Employees
Location
- Sundrug Co.,Ltd.
- 1-38-1, Wakamatsucho
- Fuchu
- Tokyo
- 183-0005
- Japan
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/05/13 00:00 |
| End of Day Share Price | 2022/05/13 00:00 |
| Earnings | 2021/12/31 |
| Annual Earnings | 2021/03/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.